Publications by authors named "Irina Piatkov"

Article Synopsis
  • Pharmacogenetics explores how an individual's genetic makeup influences their response to drugs, especially in the context of monoclonal antibodies (mAbs) used in cancer therapy.
  • Since the introduction of Rituximab in 1997, mAbs have become a leading method in cancer treatment, with several new and effective options emerging.
  • The effectiveness of mAb therapies can vary greatly based on genes related to antibody presentation and metabolism, highlighting the importance of studying patient genetics to optimize treatment outcomes.
View Article and Find Full Text PDF

Clozapine (CZ) has superior efficacy to other antipsychotic agents in the treatment of schizophrenia and has been extensively used in clinical practice. ATP-binding cassette (ABC) transporter proteins are responsible for the distribution of various molecules as well as drugs across extracellular and intracellular membranes, including the blood-brain barrier. Genetic variations in these proteins can account for differences in treatment response.

View Article and Find Full Text PDF
Article Synopsis
  • Clozapine (CZ) is an effective treatment for resistant schizophrenia, but its use is limited due to side effects like weight gain and diabetes.
  • A study of 187 patients found that 39% carried the CYP2C19*17 genetic variant, which was linked to higher levels of norclozapine (NCZ) and lower blood glucose and HbA1c levels.
  • Patients with the CYP2C19*17 variant experienced lower rates of diabetes and greater clinical improvement, indicating that genetic factors may influence response to clozapine treatment and metabolic side effects.
View Article and Find Full Text PDF

An optimal clozapine serum level is required for both optimization of clinical response and minimization of troublesome or some of the life-threatening side effects. Serum levels can be influenced by comedication that can cause phenoconversion. When norclozapine/clozapine serum levels and ratios are consistently and significantly lower/higher than expected and there are no concomitant drugs that could account for these findings, further investigation of the genetic variants of CYP1A2, 2D6 and 3A4 are warranted.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined a female non-smoker with unexpectedly high clozapine/norclozapine serum levels.
  • Researchers used RFLP genotype methods to identify genetic polymorphisms affecting clozapine metabolism.
  • The findings highlight the importance of pharmacogenetic testing in optimizing clozapine dosing for better treatment outcomes and fewer side effects.
View Article and Find Full Text PDF

Thousands of samples for pharmacogenetic tests have been analysed in our laboratory since its establishment. In this article we describe some of the most interesting cases of CYP poor metabolisers associated with adverse reactions to psychotropic drugs. Prevention of disease/illness, including Adverse Drug Reaction (ADR), is an aim of modern medicine.

View Article and Find Full Text PDF

Warfarin is a widely used anticoagulant in the treatment and prevention of thrombosis, in the treatment for chronic atrial fibrillation, mechanical valves, pulmonary embolism, and dilated cardiomyopathy. It is tasteless and colorless, was used as a poison, and is still marketed as a pesticide against rats and mice. Several long-acting warfarin derivatives-superwarfarin anticoagulants-such as brodifacoum, diphenadione, chlorophacinone, bromadiolone, are used as pesticides and can produce profound and prolonged anticoagulation.

View Article and Find Full Text PDF

Genetic polymorphisms can significantly affect the enzyme activity of the drug metabolizing enzyme Cytochrome P450 2D6 (CYP2D6; OMIM 124030). Accordingly, CYP2D6 genotyping is considered as a valid approach to predict the individual CYP2D6 metabolizing status. We introduce ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry (ICEMS) as method for the characterization of single base variants, small deletions, and insertions in the CYP2D6 gene.

View Article and Find Full Text PDF

The variation in individual responses to psychotropic drug treatment remains a critical problem in the management of psychotic disorders. Although most patients will experience remission, some patients may develop drug-induced adverse effects that may range from troublesome to life threatening. Antidepressants are freely prescribed by general practitioners, and there should be constant awareness in the medical community about possible serious side effects.

View Article and Find Full Text PDF

Responses to toxins and drugs, even to standard medical drug treatment regimens, can vary significantly between individuals. Similar dosages can have divergent results due to polymorphisms in the genes that code for the enzymes responsible for the metabolism of drugs. The focus of this report is to describe our exploration of the personalized medicine approach for patient care at Sydney West Area Health Service.

View Article and Find Full Text PDF

Arecoline (methyl-1,2,5,6-tetrahydro-1-methyl nicotinate) is an alkaloid found in the areca catechu nut which is a major component of the 'betel quid' chewed by a large proporation of the population in India, South Asia and the South Pacific islands. It is commonly associated with the development of oral leukoplakia, oral submucous fibrosis and oral cancer. We have developed a new ion-pairing reversed-phase high-performance liquid chromatographic (HPLC) method for the determination of arecoline in saliva, using arecaidine (1,2,5,6-tetrahydro-1-methylnicotinic acid) as an internal standard.

View Article and Find Full Text PDF